卖什么
Nomic is doing for proteins what Illumina has done for DNA
商业模式拆解
买家：谁掌握预算？
未核实Pharma/biotech R&D and academic labs (150+ institutions supported).
触发点：什么让他们现在购买？
Need affordable, high-throughput protein profiling at scale for discovery and translational studies.
工作流：什么输入变成什么输出？
Customer ships samples to Nomic service, nELISA profiles 1,000 proteins (Omni 1000) or custom panels, data returned through a portal.
经济账：省了什么，怎么收费？
Fee-for-service assay profiling; markets "the $50 proteome" (1,000 proteins quantified per sample).
渠道：怎么接触到客户？
Contact/Start now sales, partnerships (Broad Clinical Labs, Sanger), grants and publications.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2020 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.